161 related articles for article (PubMed ID: 35740309)
1. Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature.
Monti M; Lunardini S; Magli IA; Campi R; Primiceri G; Berardinelli F; Amparore D; Terracciano D; Lucarelli G; Schips L; Ferro M; Marchioni M
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740309
[TBL] [Abstract][Full Text] [Related]
2. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
Butz H; Nofech-Mozes R; Ding Q; Khella HWZ; Szabó PM; Jewett M; Finelli A; Lee J; Ordon M; Stewart R; Krylov S; Yousef GM
Eur Urol Focus; 2016 Jun; 2(2):210-218. PubMed ID: 28723537
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
4. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
[TBL] [Abstract][Full Text] [Related]
5. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
Front Genet; 2020; 11():449. PubMed ID: 32508877
[No Abstract] [Full Text] [Related]
6. Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer.
Du M; Giridhar KV; Tian Y; Tschannen MR; Zhu J; Huang CC; Kilari D; Kohli M; Wang L
Oncotarget; 2017 Sep; 8(38):63703-63714. PubMed ID: 28969022
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms.
Yang Q; Wei B; Peng C; Wang L; Li C
Curr Res Transl Med; 2022 Jan; 70(1):103315. PubMed ID: 34837760
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
[TBL] [Abstract][Full Text] [Related]
10. Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer.
Tang S; Cheng J; Yao Y; Lou C; Wang L; Huang X; Zhang Y
Front Genet; 2020; 11():237. PubMed ID: 32256526
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
Xiao CT; Lai WJ; Zhu WA; Wang H
Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
[TBL] [Abstract][Full Text] [Related]
12. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
[TBL] [Abstract][Full Text] [Related]
13. Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer.
Li Z; Li LX; Diao YJ; Wang J; Ye Y; Hao XK
Cancer Manag Res; 2021; 13():25-35. PubMed ID: 33442291
[TBL] [Abstract][Full Text] [Related]
14. The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.
Guo T; Wang Y; Jia J; Mao X; Stankiewicz E; Scandura G; Burke E; Xu L; Marzec J; Davies CR; Lu JJ; Rajan P; Grey A; Tipples K; Hines J; Kudahetti S; Oliver T; Powles T; Alifrangis C; Kohli M; Shaw G; Wang W; Feng N; Shamash J; Berney D; Wang L; Lu YJ
Front Cell Dev Biol; 2020; 8():602493. PubMed ID: 33490068
[TBL] [Abstract][Full Text] [Related]
15. Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.
Ryu KJ; Lee JY; Choi ME; Yoon SE; Cho J; Ko YH; Shim JH; Kim WS; Park C; Kim SJ
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261029
[TBL] [Abstract][Full Text] [Related]
16. MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients.
Kovacova J; Juracek J; Poprach A; Kopecky J; Fiala O; Svoboda M; Fabian P; Radova L; Brabec P; Buchler T; Slaby O
Cancer Genomics Proteomics; 2019; 16(5):353-359. PubMed ID: 31467229
[TBL] [Abstract][Full Text] [Related]
17. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.
Kinget L; Roussel E; Verbiest A; Albersen M; Rodríguez-Antona C; Graña-Castro O; Inglada-Pérez L; Zucman-Rossi J; Couchy G; Job S; de Reyniès A; Laenen A; Baldewijns M; Beuselinck B
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205829
[TBL] [Abstract][Full Text] [Related]
19. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
Liu X; Chu KM
J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
